scholarly journals Soft tissue augmentation applying a collagenated porcine dermal matrix during second stage surgery: A prospective multicenter case series

2019 ◽  
Vol 21 (5) ◽  
pp. 923-930 ◽  
Author(s):  
Kai R. Fischer ◽  
Tiziano Testori ◽  
Hannes Wachtel ◽  
Sven Mühlemann ◽  
Arndt Happe ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Case Series ◽  
Soft Tissue Augmentation ◽  
Dermal Matrix ◽  
Second Stage ◽  
Tissue Augmentation

Soft Tissue Augmentation of the Lips Using AlloDerm: A Review of Postoperative Complications

2002 ◽  
Vol 19 (4) ◽  
pp. 229-232
Author(s):  
Francis R. Palmer ◽  
Keith A. Hurvitz ◽  
B. Koire ◽  
Uttam K. Sinha ◽  
Dale H. Rice
Keyword(s):  
Soft Tissue ◽  
Postoperative Complications ◽  
Complete Resolution ◽  
Soft Tissue Augmentation ◽  
Postoperative Complication Rate ◽  
Dermal Matrix ◽  
Lip Augmentation ◽  
The Past ◽  
Tissue Augmentation ◽  
Outpatient Intervention

Introduction: Lip augmentation continues to gain popularity. To keep up with demand, physicians are continually seeking out safer and more efficient methods. We have been using acellular human dermal matrix or AlloDerm (LifeCell Corp, Branchburg, NJ) for the past 7 years with dependable results. In this study, we present a 5-year review of our postoperative complications using AlloDerm for soft tissue augmentation of the lips. Materials and Methods: We reviewed the postoperative courses of 104 patients (117 procedures in total) who received AlloDerm lip implants. Signs of postoperative infection, hematoma, seroma, rejection, or extrusion were specifically noted. Results: Of the 117 procedures performed, only 7 postoperative complications were noted. All resolved easily with outpatient intervention. None of the AlloDerm implants had to be removed as a result of these complications. Conclusions: Our results show that lip augmentation using AlloDerm has a low postoperative complication rate. In addition, those complications encountered can be easily treated with complete resolution.

scholarly journals Porcine Acellular Dermal Matrix: An Alternative to Connective Tissue Graft—A Narrative Review

2021 ◽  
Vol 2021 ◽  
pp. 1-7
Author(s):  
Shashi Dadlani
Keyword(s):  
Soft Tissue ◽  
Connective Tissue ◽  
Acellular Dermal Matrix ◽  
Soft Tissue Augmentation ◽  
Dermal Matrix ◽  
Connective Tissue Graft ◽  
Tissue Graft ◽  
Tissue Augmentation ◽  
Porcine Acellular Dermal Matrix ◽  
Acellular Dermal

Porcine acellular dermal matrix has recently been introduced in dentistry as an alternative to the gold standard connective tissue graft especially for the use in gingival recession treatments and soft tissue augmentation in implant surgery. Connective tissue grafts are inconvenient and require a second surgical site leading to greater morbidity, longer surgical procedures, and a more painful postoperative phase for the patient. Other options such as allografts have ethical concerns and are less available in Europe. Thus, dental professionals have sought other techniques and materials. Porcine acellular dermal matrix results in periodontal recession treatment with a gain in recession coverage as well as increased keratinized tissue and soft tissue augmentation. This leads to more keratinized mucosa and greater tissue thickness. Many studies have been published using collagen matrices, but a few strictly use porcine acellular dermal matrix, which have been studied in prospective randomized clinical trials with a large number of patients and longer follow-up periods (more than 5 years). Nevertheless, more data are needed to confirm that the porcine acellular dermal matrix is a suitable alternative although its favourable results to date suggest a positive future.

Threatened ventriculostomy shunt exposure: augmenting native soft tissue coverage with acellular dermal matrix graft

2012 ◽  
Vol 10 (4) ◽  
pp. 324-326
Author(s):  
Thomas Ridder ◽  
Shuhao Zhang ◽  
Gary Tye ◽  
Jennifer L. Rhodes
Keyword(s):  
Soft Tissue ◽  
Pediatric Population ◽  
Case Series ◽  
Acellular Dermal Matrix ◽  
Soft Tissue Augmentation ◽  
Shunt Revision ◽  
Soft Tissue Coverage ◽  
Dermal Matrix ◽  
History Of ◽  
Acellular Dermal

Avoiding threatened ventriculostomy shunt exposure in the pediatric population remains a difficult problem for the neurosurgeon and reconstructive surgeon. In this case series, the authors present a novel method of augmenting scalp soft tissue with acellular dermal matrix (ADM) in patients with a history of ventricular shunt revisions. Soft tissue augmentation with ADM successfully prevented shunt exposure in 3 patients with a history of shunt revision due to impending exposure following conventional techniques.

Sign in / Sign up

Export Citation Format

Share Document